Frey syndrome secondary to submaxillectomy and botulinic treatment;Sindrome de frey por submaxilectomia y tratamiento con toxina botulinica

Medicina

Volumn 67, Issue 5, 2007, Pages 478-480

  Baez, Alejandra ^a   Paleari, Julieta ^b   Duran, Maria Nöel ^a   Rudy, Tamara ^a   Califano, Ines ^a   Barbosa, Nicolas ^a   Parera, Ignacio Casas ^a  

^a Instituto de Oncologia Angel H Roffo   (Argentina)

^b Hospital Zonal General de Agudos Dr Carlos Bocalandro   (Argentina)

Author keywords

Botulinum toxin; Frey syndrome; Submaxillectomy

Indexed keywords

BOTULINUM TOXIN A; CISPLATIN; DOXORUBICIN; MUSCLE RELAXANT AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; FREY SYNDROME; HISTOPATHOLOGY; HUMAN; MALE; MAXILLA RESECTION; MULTIPLE CYCLE TREATMENT; PATIENT SATISFACTION; PREOPERATIVE CARE; SUBMANDIBULAR GLAND; SWEATING; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; MAXILLA; NECK DISSECTION; PAROTID GLAND; POSTOPERATIVE COMPLICATION; SWEAT GLAND DISEASE; THYROID TUMOR;

ADULT; BOTULINUM TOXIN TYPE A; HUMANS; MALE; MAXILLA; NECK DISSECTION; NEUROMUSCULAR AGENTS; PAROTID GLAND; POSTOPERATIVE COMPLICATIONS; SUBMANDIBULAR GLAND; SWEATING, GUSTATORY; THYROID NEOPLASMS;

EID: 36049037189     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Eckardt A, Kuettner C. Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A. Head & Neck 2003; 25: 624-8.
2. Andersen PE. Cervical metastases. In: Garth Close L, Larson DL, Shah JP (eds). Essentials of head and neck Oncology. New York: Thieme Publisher, 1998, Chapter 24, p 256-65.
3. Rodopoulou S, Keramidas E, Metaxotos N, Tagaris G, Tsati E, Ioannovich J. Treatment of Frey's syndrome using botulinum toxin type A. Eur J Plast Surg 2001; 24: 297-302.
4. Kowalski JW, Eadi N, Dagget S, Iai P-Y. Validity and reliability of the hyperhidrosis disease severity scale (HDSS). J Am Acad Dermatol 2004; 50: P51.
5. Duphenix M. Observations sur les fistules du canal salivaire de Stenson. I. Sur une playe compliquée à la joue où le canal salivaire fut déchiré. Mémoires de I'Académie Royale de Chirurgie, 1757; III: 431-9.
6. Frey L. Le syndrome du nerf auriculo-temporal. Rev Neurol 1923; II: 97-104.
7. Glaister DH, Hearnshaw JR, Heffron PF, Peck AW. The mechanism of post-parotidectomy gustatory sweating (The auriculo-temporal syndrome). Br Med J 1958; II: 942-6.
8. Santos RC, de Salles Chagas JF, Freire Pinto Bezerra T, et al. Frey syndrome prevalence after partial parotidectomy. Rev Bras Otorrinolaringol 2006, 72: 112-5.
9. Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity and immunology. Muscle Nerve 1997; Suppl 6: 146-68.
10. Kreyden OP, Scheidegger EP. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol 2004; 22: 40-4.
11. Kyrmizakis DE, Pangalos A, Papadakis CH, et al. The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes. J Oral Maxillofac Surg 2004; 62: 840-4.
12. Cavalot AL, Palonta F, Preti G, et al. Post-parotidectomy Frey's syndrome. Treatment with botulinum toxin type A. Acta Otorhinolaryngol Ital 2000; 20: 187-91.
13. Conley J. Gustatory sweating syndrome in salivary glands and the facial nerve. Stuttgart: George Thieme Publishers, 1975, p 51-6.
14. Clayman MA, Clayman SM, Seagle MB. A review of the surgical and medical treatment of Frey Syndrome. Ann Plast Surg 2006; 57: 581-4.
15. Laskawi R, Dobrik C, Schönbeck C. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome). Laryngoscope 1998; 108: 381-4.